×
Apyx Medical Net Profit Margin 2010-2025 | APYX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Apyx Medical net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Apyx Medical Net Profit Margin 2010-2025 | APYX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Apyx Medical net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$219.8B
Boston Scientific (BSX)
$156.6B
Stryker (SYK)
$152.9B
EssilorLuxottica (ESLOY)
$137.9B
Medtronic (MDT)
$118B
Lonza Group Ag (LZAGY)
$49.3B
Haleon (HLN)
$43.6B
ResMed (RMD)
$40.1B
GE HealthCare Technologies (GEHC)
$35.6B
Agilent Technologies (A)
$34B
Terumo (TRUMY)
$25.6B
Koninklijke Philips (PHG)
$24.7B
Insulet (PODD)
$20.6B
Zimmer Biomet Holdings (ZBH)
$19B
Baxter (BAX)
$14.6B
Smith & Nephew SNATS (SNN)
$13.7B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$6.9B
Lantheus Holdings (LNTH)
$5B
Perrigo (PRGO)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.1B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.8B
AtriCure (ATRC)
$1.6B
Acuren (TIC)
$1.4B